Mark Peterson

Future Standard launches a semi-liquid PE fund, betting on the middle market's resilience. Can it deliver private returns with public-like access?

KULR Technology developed a key directed energy weapon battery in record time. But can its engineering speed outpace the risks of its bold crypto strategy?

Liberty Defense taps a specialized partner for HEXWAVE deployment, a strategic move to overcome financial hurdles and accelerate growth in the security market.

Sarepta's clinical progress in myotonic dystrophy signals a major diversification beyond Duchenne, leveraging a high-stakes siRNA partnership.

CSW Industrials expands its Specialized Reliability Solutions segment with the acquisitions of Hydrotex and ProAction Fluids, signaling a strategic focus on niche markets and infrastructure support.

Global steel giant ArcelorMittal cancels nearly 78 million treasury shares, signaling confidence and a commitment to returning capital to investors. The move is expected to significantly impact earnings per share.

Cenovus Energy completed a $2.6 billion debt offering and concurrent redemption, bolstering its financial position amidst a shifting energy landscape and signaling optimism for the Canadian energy sector.

Texas-based Cipher Mining secures $333M to expand its data center footprint, betting on HPC demand despite cryptocurrency market uncertainties. A deep dive into the company's strategy and its impact on the infrastructure landscape.

The energy conversion and control systems leader is boosting its share repurchase program to $1.8 billion, underscoring strong financial health and a commitment to delivering value to shareholders amid a dynamic market.

KBR and Axiom Space complete critical thermal vacuum test of next-gen lunar spacesuit, crucial for Artemis III mission. A historic facility and commercial partnerships drive innovation for a return to the Moon.

Bright Scholar Education is going private amid increased scrutiny of Chinese education firms and a broader trend of delistings. A deep dive into the deal, the company's financials, and the future of international education.

Longeveron presents promising Phase 2 data on its cell therapy for mild Alzheimer's at CTAD 2025. While the science offers hope, the biotech faces a challenging financial landscape as it pursues pivotal trials.

DeFi Development Corp. is making waves as the first U.S. public company to center its treasury around Solana. But is this bold move a harbinger of future finance, or a risky gamble for investors?

Biotech firm Cellectis unveils promising non-viral gene editing process with significantly improved efficiency. Experts believe this technology could lower costs and broaden access to life-saving therapies.

The AI-driven drug discovery firm is pushing its causal AI platform, but faces financial hurdles and a competitive landscape. Can its unique approach overcome market skepticism?

Nasdaq-listed DeFi Development Corp. is expanding its Solana holdings through a partnership with Loopscale, signaling a growing trend of public companies diversifying into crypto yield-generating assets. Is this a new era for institutional DeFi?

The lumber and building materials manufacturer is renewing its share repurchase program, suggesting optimism despite cooling housing trends. Experts weigh in on the company's financial health and industry outlook.

Highwoods Properties' $223M acquisition of 6Hundred at Legacy Union signals a strategic shift in Charlotte’s office market, emphasizing quality and long-term stability amid evolving work trends.

Regional lender Middlefield Banc Corp. announces a steady dividend, bolstered by strong Q3 performance and strategic lending in Ohio. Analysts see continued stability amidst a changing economic landscape.

Raphael Pharmaceutical advances a novel, THC/CBD-free cannabinoid treatment for rheumatoid arthritis, filing a provisional patent and reporting positive early clinical results. Is this a breakthrough for autoimmune therapy?